Want to see JP:4492 full AI Analyst Report?
Top Page
Genetec Corp.
(4492)
Select Model
Select Model
Rating:62Neutral
Price Target:
¥406.00
▼(-15.24% Downside)
Action:Reiterated
Date:08/19/26
The score is supported primarily by attractive valuation (low P/E and high dividend yield), but is held back by financial quality concerns—especially the sharp 2026 cash-flow deterioration and higher leverage—and by weak technical signals with the stock trading below key moving averages.
Positive Factors
Accelerating Revenue Growth
The acceleration in revenue growth indicates strengthening demand and expanding business activity. If sustained, it can improve operating leverage, support continued investment in software offerings, and reinforce the company’s market position over the next several quarters.
Negative Factors
Sharp Cash-Flow Deterioration
The latest collapse in operating and free cash flow, alongside very low cash conversion, raises concern that reported earnings are not translating into liquidity. Working-capital volatility or collection pressure could constrain reinvestment and financial resilience.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating Revenue Growth
The acceleration in revenue growth indicates strengthening demand and expanding business activity. If sustained, it can improve operating leverage, support continued investment in software offerings, and reinforce the company’s market position over the next several quarters.
Read all positive factors
Genetec Corp. (4492) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥4.38B
Dividend Yield5.74%
Average Volume (3M)20.16K
Price to Earnings (P/E)8.9
Beta (1Y)0.37
Revenue Growth28.33%
EPS Growth27.93%
CountryJP
Employees648
SectorGeneral
Sector StrengthN/A
IndustrySoftware - Application
Share Statistics
EPS (TTM)43.11
Shares Outstanding11,727,700
10 Day Avg. Volume14,300
30 Day Avg. Volume20,160
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)2.00
Price to Sales (P/S)0.50
P/FCF Ratio116.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Genetec Corp. Business Overview & Revenue Model
Company Description
Genetec Corporation is a Japanese company specializing in software development. Its operations are structured across three main business segments: Digital Solutions, Engineering Solutions, and Cocodayo. The Digital Solutions division focuses on cr...
How the Company Makes Money
null...
Genetec Corp. Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
62
Positive
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.03B | 10.98B | 8.12B | 7.15B | 5.86B | 4.68B |
| Gross Profit | 4.18B | 4.15B | 3.27B | 2.91B | 2.32B | 1.96B |
| EBITDA | 1.07B | 1.06B | 849.75M | 775.92M | 259.62M | 226.31M |
| Net Income | 497.35M | 510.44M | 421.12M | 414.77M | 23.76M | 56.64M |
Balance Sheet | ||||||
| Total Assets | 6.27B | 6.91B | 7.15B | 4.52B | 4.12B | 3.25B |
| Cash, Cash Equivalents and Short-Term Investments | 1.59B | 1.60B | 1.99B | 1.17B | 1.08B | 1.04B |
| Total Debt | 1.82B | 2.07B | 2.26B | 640.00M | 976.09M | 50.62M |
| Total Liabilities | 3.70B | 4.19B | 4.75B | 2.31B | 2.26B | 1.39B |
| Stockholders Equity | 2.57B | 2.73B | 2.40B | 2.21B | 1.87B | 1.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 46.85M | 384.76M | 578.85M | -322.73M | -117.29M |
| Operating Cash Flow | 0.00 | 112.60M | 451.42M | 602.37M | -223.12M | -24.03M |
| Investing Cash Flow | 0.00 | -47.84M | -388.73M | -55.73M | -439.20M | -98.15M |
| Financing Cash Flow | 0.00 | -398.87M | 655.92M | -410.02M | 714.93M | -94.71M |
Genetec Corp. Technical Analysis
Negative
479.00
Price Trends
398.34
Negative
411.85
Negative
434.31
Negative
Market Momentum
-7.90
Positive
41.93
Neutral
48.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4492, the sentiment is Negative. The current price of 479 is above the 20-day moving average (MA) of 383.85, above the 50-day MA of 398.34, and above the 200-day MA of 434.31, indicating a bearish trend. The MACD of -7.90 indicates Positive momentum. The RSI at 41.93 is Neutral, neither overbought nor oversold. The STOCH value of 48.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4492.
Genetec Corp. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥6.65B | 11.91 | ― | 1.87% | 6.46% | 38.58% | |
76 Outperform | ¥5.93B | 37.24 | ― | ― | 7.04% | -67.36% | |
74 Outperform | ¥5.46B | 10.29 | ― | 2.28% | 16.86% | -14.98% | |
68 Neutral | ¥7.04B | 15.68 | ― | ― | 23.42% | 457.78% | |
62 Neutral | ¥4.38B | 8.88 | ― | 4.06% | 28.33% | 27.93% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
44 Neutral | ¥5.61B | 177.42 | ― | ― | -0.48% | ― |
* General Sector Average
JP:4492
Genetec Corp.
383.00
-90.79
-19.16%
JP:3826
System Integrator Corp.
497.00
70.30
16.47%
JP:4397
TeamSpirit, Inc.
425.00
-153.00
-26.47%
JP:4491
Computer Management Co., Ltd.
3,260.00
339.60
11.63%
JP:5033
Nulab Inc.
953.00
96.00
11.20%
JP:7527
SystemSoft Corporation
55.00
-5.00
-8.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.